|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA03020087
|
Leukotriene B3
|
5S,12R-dihydroxy-6Z,8E,10E-eicosatrienoic acid
|
FA 20:3;O2
|
C20H34O4
|
338.245711
|
|
LMFA03040012
|
Lipoxin A5
|
5S,6R,15S-trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid
|
FA 20:5;O3
|
C20H30O5
|
350.209326
|
|
LMFA03010248
|
PGD1-d4
|
9alpha,15S-dihydroxy-11-oxo-prost-13E-en-1-oic-3,3,4,4-d4 acid
|
|
C20H30D4O5
|
358.265733
|
|
LMFA03010245
|
13,14-dihydro-15-keto-tetranor Prostaglandin D2
|
9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostanoic acid
|
FA 16:3;O3
|
C16H26O5
|
298.178025
|
|
LMFA03010246
|
13,14-dihydro-15-keto-tetranor Prostaglandin E2
|
11R-hydroxy-9,15-dioxo-2,3,4,5-tetranor-prostanoic acid
|
FA 16:3;O3
|
C16H26O5
|
298.178025
|
|
LMFA03010247
|
tetranor-PGJM
|
11,15-dioxo-2,3,4,5-tetranor-9-prosten-1,20-dioic acid
|
FA 16:5;O4
|
C16H22O6
|
310.141640
|
|
LMFA03110352
|
5-F3t-IsoP
|
(E,5S)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(2Z,5Z)-octa-2,5-dienyl]cyclopentyl]-5-hydroxyhept-6-enoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03080025
|
(+/-)11,12-EpETrE-d11
|
(+-)11(12)-epoxy-5Z,8Z,14Z-eicosatrienoic-16,16,17,17,18,18,19,19,20,20,20-d11 acid
|
|
C20H21D11O3
|
331.304190
|
|
LMFA03050033
|
(+/-)11,12-DiHETrE-d11
|
(+-)11,12-dihydroxy-5Z,8Z,14Z-eicosatrienoic-16,16,17,17,18,18,19,19,20,20,20-d11 acid
|
|
C20H23D11O4
|
349.314755
|
|
LMFA03050034
|
(+/-)14,15-DiHETrE-d11
|
14,15-dihydroxy-5Z,8Z,11Z-eicosatrienoic 16,16,17,17,18,18,19,19,20,20,20-d11 acid
|
|
C20H23D11O4
|
349.314755
|
|
LMFA03080026
|
(+/-)5,6-EpETrE-d11
|
(+/-)5(6)-epoxy-8Z,11Z,14Z-eicosatrienoic-16,16,17,17,18,18,19,19,20,20,20-d11
|
|
C20H21D11O3
|
331.304190
|
|
LMFA03080027
|
(+/-)8,9-EpETrE-d11
|
(+/-)8(9)-epoxy-5Z,11Z,14Z-eicosatrienoic-16,16,17,17,18,18,19,19,20,20,20-d11
|
|
C20H21D11O3
|
331.304190
|
|
LMFA03050035
|
(+/-)8,9-DiHETrE-d11
|
(+/-)8,9-dihydroxy-5Z,11Z,14Z-eicosatrienoic-16,16,17,17,18,18,19,19,20,20,20-d11
|
|
C20H23D11O4
|
349.314755
|
|
LMFA03010249
|
13,14-dihydro-15-keto-PGE2-d4
|
9,15-dioxo-11R-hydroxy-5Z-prostenoic 3,3,4,4-d4 acid
|
|
C20H28D4O5
|
356.250082
|
|
LMFA03010250
|
15-deoxy-delta-12,14-PGJ2-d4
|
11-oxo-prosta-5Z,9,12E,14E-tetraen-1-oic-3,3,4,4-d4 acid
|
|
C20H24D4O3
|
320.228952
|
|
LMFA03110353
|
8-isoPGF2alpha-d4
|
9alpha,11alpha,15S-trihydroxy-(8beta)-prosta-5Z,13E-dien-1-oic-3,3,4,4-d4 acid
|
|
C20H30D4O5
|
358.265733
|
|
LMFA03010251
|
PGB2-d4
|
9-oxo-15S-hydroxy-prosta-5Z,8(12),13E-trien-1-oic-3,3,4,4-d4 acid
|
|
C20H26D4O4
|
338.239517
|
|
LMFA03140014
|
Resolvin E1-d4
|
5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic 6,7,14,15-d4 acid
|
|
C20H26D4O5
|
354.234432
|
|
LMFA03070062
|
15S-HEPE-d5
|
15S-hydroxy-5Z,8Z,11Z,13E,17Z-eicosapentaenoic-19,19,20,20,20-d5 acid
|
|
C20H25D5O3
|
323.250879
|
|
LMFA03020088
|
LTC4-d5
|
5S-hydroxy-6R-(S-glutathionyl),7E,9E,11Z,14Z-eicosatetraenoic-19,19,20,20,20-d5 acid
|
|
C30H42D5N3O9S
|
630.334686
|
|
LMFA03020089
|
LTD4-d5
|
5S-hydroxy-6R-(S-cysteinylglycinyl)),7E,9E,11Z,14Z-eicosatetraenoic-19,19,20,20,20-d5 acid
|
|
C25H35D5N2O6S
|
501.292092
|
|
LMFA03020090
|
LTE4-d5
|
5S-hydroxy-6R-(S-cysteinyl)-7E,9E,11Z,14Z-eicosatetraenoic-19,19,20,20,20-d5 acid
|
|
C23H32D5NO5S
|
457.302262
|
|
LMFA03040013
|
Lipoxin A4-d5
|
5S,6R,15S-trihydroxy-7E,9E,11Z,13E-eicosatetraenoic-19,19,20,20,20-d5 acid
|
|
C20H27D5O5
|
357.256359
|
|
LMFA03010252
|
tetranor-PGDM-d6
|
9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostan-1,20-dioic-17,17,18,18,19,19-d6 acid
|
|
C16H18D6O7
|
334.189866
|
|
LMFA03000036
|
15-HEDE
|
15-hydroxy-11Z,13E-eicosadienoic acid
|
FA 20:2;O
|
C20H36O3
|
324.266446
|
|
LMFA03110354
|
8,12-iso-iPF2alpha-VI
|
5,9S,11R-trihydroxy-6E,14Z-prostadienoic acid-cyclo[8R,12S]
|
FA 20:3;O3
|
C20H34O5
|
354.240626
|
|
LMFA03110355
|
8-F3t-IsoP
|
8S,12S,14R-trihydroxy-5Z,9E,17Z-prostatrienoic acid-cyclo[11S,15R]
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03110356
|
8-F1t-dihomo-PhytoP-DGLA
|
10-((1S,2S,3R,5R)-3,5-dihydroxy-2-(pentan-1-yl)cyclopentyl)-8S-hydroxy-9E-octenoic acid
|
FA 20:2;O3
|
C20H36O5
|
356.256276
|
|
LMFA03080028
|
(+/-)14,15-EpETrE-d11
|
14,15-epoxy-5Z,8Z,11Z-eicosatrienoic-16,16,17,17,18,18,19,19,20,20,20-d11 acid
|
|
C20H21D11O3
|
331.304190
|
|
LMFA03060122
|
9(S)-HETE-d8
|
9S-hydroxy-eicosa-5Z,7E,11Z,14Z-tetraenoic-5,6,8,9,11,12,14,15-d8 acid
|
|
C20H24D8O3
|
328.285359
|
|
LMFA03050036
|
12S-HETrE
|
12S-hydroxy-8Z,10E,14Z-eicosatrienoic acid
|
|
C20H34O3
|
322.250796
|
|
LMFA03000037
|
(+/-)14(15)-EpEDE
|
(+/-)14,15-epoxy-8Z,11Z-eicosadienoic Acid
|
FA 20:3;O
|
C20H34O3
|
322.250796
|
|
LMFA03060124
|
(+/-)12-HpETE
|
12-hydroperoxy-5Z,8Z,10E,14Z-eicosatetraenoic acid
|
FA 20:4;O2
|
C20H32O4
|
336.230061
|
|
LMFA03060125
|
(+/-)15-HETE-d8
|
15-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic acid-d8
|
|
C20H24D8O3
|
328.285359
|
|
LMFA03110357
|
18-epi-18-F3t-IsoP
|
12S,14R,18R-trihydroxy-5Z,8Z,13E-prostatrienoic acid-cyclo[11S,15S]
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03110358
|
Tetranor-4R-4-F4t-NeuroP
|
(5Z,8Z)-10-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)deca-5,8-dienoic acid
|
FA 19:4;O3
|
C19H30O5
|
338.209326
|
|
LMFA03110359
|
8-epi-8-F3t-IsoP
|
8R,12S,14R-trihydroxy-5Z,9E,17Z-prostatrienoic acid-cyclo[11S,15R]
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03010253
|
2,3-dinor-15-epi-15-F2t-IsoP
|
9S,11R,15R-trihydroxy-2,3-dinor-5Z,13E-prostadienoic acid
|
FA 18:3;O3
|
C18H30O5
|
326.209326
|
|
LMFA03050037
|
12S-HETrE
|
12S-hydroxy-5Z,8Z,12Z-eicosatrienoic acid
|
FA 20:3;O
|
C20H34O3
|
322.250796
|
|
LMFA03110360
|
(+/-)17-F2t-dihomo-IsoP
|
1a,1b-dihomo-11S,13R,17-trihydroxy-7Z,15E-prostadienoic acid-cyclo[10S,14R]
|
FA 22:3;O3
|
C22H38O5
|
382.271926
|
|
LMFA03110361
|
5-epe-F3t-IsoP
|
(E,5R)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(2Z,5Z)-octa-2,5-dienyl]cyclopentyl]-5-hydroxyhept-6-enoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03110362
|
18-F3t-IsoP
|
12S,14R,18S-trihydroxy-5Z,8Z,13E-prostatrienoic acid-cyclo[11S,15S]
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03010254
|
13-epi-13-F1t-PhytoP
|
9S,11R,15R-trihydroxy-2,3-dinor-13E-prostaenoic acid-cyclo[8S,12R]
|
FA 18:2;O3
|
C18H32O5
|
328.224976
|
|
LMFA03110363
|
ent-7(RS)-7-F2t-dihomo-IsoP
|
1a,1b-dihomo-7,11R,13S-trihydroxy-8E,16Z-prostadienoic acid-cyclo[10R,14S]
|
FA 22:3;O3
|
C22H38O5
|
382.271926
|
|
LMFA03110364
|
8,12-iso-iPF2alpha-VI-d11
|
5,9S,11R-trihydroxy-6E,14Z-prostadienoic acid-cyclo[8R,12S]-(d11)
|
|
C20H23D11O5
|
365.309670
|
|
LMFA03010257
|
PGE2-d9
|
9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic-17,17,18,18,19,19,20,20,20-d9 acid
|
|
C20H23D9O5
|
361.281466
|
|
LMFA03010256
|
PGD2-d9
|
9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic-17,17,18,18,19,19,20,20,20-d9 acid
|
|
C20H23D9O5
|
361.281466
|
|
LMFA03010255
|
13,14-dihydro-15-keto-PGD1
|
9S-hydroxy-11,15-dioxo-prostanoic acid
|
FA 20:3;O3
|
C20H34O5
|
354.240626
|
|
LMFA03060123
|
4-HETE
|
(+/-)-4-hydroxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235146
|
|
LMFA03110365
|
C21-15-F2t-IsoP
|
(Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxynon-1-enyl]cyclopentyl]hept-5-enoic acid
|
FA 21:3;O3
|
C21H36O5
|
368.256276
|